268 related articles for article (PubMed ID: 30882951)
1. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations.
Velho RV; Harms FL; Danyukova T; Ludwig NF; Friez MJ; Cathey SS; Filocamo M; Tappino B; Güneş N; Tüysüz B; Tylee KL; Brammeier KL; Heptinstall L; Oussoren E; van der Ploeg AT; Petersen C; Alves S; Saavedra GD; Schwartz IV; Muschol N; Kutsche K; Pohl S
Hum Mutat; 2019 Jul; 40(7):842-864. PubMed ID: 30882951
[TBL] [Abstract][Full Text] [Related]
2. Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma.
Liu S; Zhang W; Shi H; Meng Y; Qiu Z
Gene; 2014 Feb; 535(2):294-8. PubMed ID: 24316125
[TBL] [Abstract][Full Text] [Related]
3. Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.
Wang Y; Ye J; Qiu WJ; Han LS; Gao XL; Liang LL; Gu XF; Zhang HW
Acta Pharmacol Sin; 2019 Feb; 40(2):279-287. PubMed ID: 29872134
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.
Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S
Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III.
Di Lorenzo G; Westermann LM; Yorgan TA; Stürznickel J; Ludwig NF; Ammer LS; Baranowsky A; Ahmadi S; Pourbarkhordariesfandabadi E; Breyer SR; Board TN; Foster A; Mercer J; Tylee K; Velho RV; Schweizer M; Renné T; Braulke T; Randon DN; Sperb-Ludwig F; de Camargo Pinto LL; Moreno CA; Cavalcanti DP; Amling M; Kutsche K; Winter D; Muschol NM; Schwartz IVD; Rolvien T; Danyukova T; Schinke T; Pohl S
Genet Med; 2021 Dec; 23(12):2369-2377. PubMed ID: 34341521
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
[TBL] [Abstract][Full Text] [Related]
7. Dilated cardiomyopathy in mucolipidosis type 2.
Carboni E; Sestito S; Lucente M; Morrone A; Zampini L; Chimenz R; Ceravolo MD; De Sarro R; Ceravolo G; Calabrò MP; Parisi F; Moricca MT; Pensabene L; Musolino D; Concolino D
J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):71-77. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000604
[TBL] [Abstract][Full Text] [Related]
8. Comparative pathology of murine mucolipidosis types II and IIIC.
Vogel P; Payne BJ; Read R; Lee WS; Gelfman CM; Kornfeld S
Vet Pathol; 2009 Mar; 46(2):313-24. PubMed ID: 19261645
[TBL] [Abstract][Full Text] [Related]
9. Disease-causing missense mutations within the N-terminal transmembrane domain of GlcNAc-1-phosphotransferase impair endoplasmic reticulum translocation or Golgi retention.
Lee WS; Jennings BC; Doray B; Kornfeld S
Hum Mutat; 2020 Jul; 41(7):1321-1328. PubMed ID: 32220096
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of 30 novel pathogenic variations in 69 unrelated Indian patients with Mucolipidosis Type II and Type III.
Pasumarthi D; Gupta N; Sheth J; Jain SJMN; Rungsung I; Kabra M; Ranganath P; Aggarwal S; Phadke SR; Girisha KM; Shukla A; Datar C; Verma IC; Puri RD; Bhavsar R; Mistry M; Sankar VH; Gowrishankar K; Agrawal D; Nair M; Danda S; Soni JP; Dalal A
J Hum Genet; 2020 Nov; 65(11):971-984. PubMed ID: 32651481
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma.
Westermann LM; Fleischhauer L; Vogel J; Jenei-Lanzl Z; Ludwig NF; Schau L; Morellini F; Baranowsky A; Yorgan TA; Di Lorenzo G; Schweizer M; de Souza Pinheiro B; Guarany NR; Sperb-Ludwig F; Visioli F; Oliveira Silva T; Soul J; Hendrickx G; Wiegert JS; Schwartz IVD; Clausen-Schaumann H; Zaucke F; Schinke T; Pohl S; Danyukova T
Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 33023972
[TBL] [Abstract][Full Text] [Related]
12. Mucolipidosis III GNPTG Missense Mutations Cause Misfolding of the γ Subunit of GlcNAc-1-Phosphotransferase.
van Meel E; Kornfeld S
Hum Mutat; 2016 Jul; 37(7):623-6. PubMed ID: 27038293
[TBL] [Abstract][Full Text] [Related]
13. GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms.
Ludwig NF; Velho RV; Sperb-Ludwig F; Acosta AX; Ribeiro EM; Kim CA; Gandelman Horovitz DD; Boy R; Rodovalho-Doriqui MJ; Lourenço CM; Santos ES; Braulke T; Pohl S; Schwartz IVD
Int J Biochem Cell Biol; 2017 Nov; 92():90-94. PubMed ID: 28918368
[TBL] [Abstract][Full Text] [Related]
14. Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB).
De Pace R; Coutinho MF; Koch-Nolte F; Haag F; Prata MJ; Alves S; Braulke T; Pohl S
Hum Mutat; 2014 Mar; 35(3):368-76. PubMed ID: 24375680
[TBL] [Abstract][Full Text] [Related]
15. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.
Kudo M; Brem MS; Canfield WM
Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621
[TBL] [Abstract][Full Text] [Related]
16. Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta.
Danyukova T; Ludwig NF; Velho RV; Harms FL; Güneş N; Tidow H; Schwartz IV; Tüysüz B; Pohl S
Hum Mutat; 2020 Jan; 41(1):133-139. PubMed ID: 31579991
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the GlcNac-1-phosphotransferase.
Braulke T; Pohl S; Storch S
J Inherit Metab Dis; 2008 Apr; 31(2):253-7. PubMed ID: 18425436
[TBL] [Abstract][Full Text] [Related]
18. Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site.
Velho RV; De Pace R; Klünder S; Sperb-Ludwig F; Lourenço CM; Schwartz IV; Braulke T; Pohl S
Hum Mol Genet; 2015 Jun; 24(12):3497-505. PubMed ID: 25788519
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III.
Zarghooni M; Dittakavi SS
Am J Med Genet A; 2009 Dec; 149A(12):2753-61. PubMed ID: 19938078
[TBL] [Abstract][Full Text] [Related]
20. Missense mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTA) in a patient with mucolipidosis II induces changes in the size and cellular distribution of GNPTG.
Tiede S; Cantz M; Spranger J; Braulke T
Hum Mutat; 2006 Aug; 27(8):830-1. PubMed ID: 16835905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
